Haoxi Health and Eaglepoint AI Partner for AI Health Management in China

The strategic partnership between Haoxi Health Technology Limited and Eaglepoint AI, a subsidiary of Global Mofy AI Limited, represents a significant convergence of marketing infrastructure and advanced generative AI capabilities within the Chinese healthcare market. By signing a three-year cooperation agreement, the two entities are positioning themselves to capture a share of the high-growth health management sector, specifically targeting the 'sub-healthy' population through a software-as-a-service (SaaS) model. This move is particularly noteworthy as it marks the first time Eaglepoint AI has deployed its proprietary Aquila data engine and multimodal model evaluation system in a healthcare-specific context, signaling a diversification strategy for Global Mofy AI beyond its traditional digital content and entertainment roots.

The technical backbone of this partnership rests on Eaglepoint AI’s Aquila data engine. In the rapidly evolving landscape of AI-enabled healthcare, the ability to process multimodal data—ranging from physiological metrics to nutritional intake—is critical for providing personalized health insights. Eaglepoint AI will lead the technical development, focusing on model training, algorithm iteration, and, perhaps most importantly, data security compliance. Given China's stringent data protection regulations, particularly regarding sensitive health information, the emphasis on compliance in the partnership agreement suggests a proactive approach to navigating the regulatory complexities of the region. The multimodal model evaluation system will likely serve as a quality control layer, ensuring that the AI's recommendations for nutrition and disease risk assessment meet clinical or safety benchmarks before reaching the end-user.

“

The technical backbone of this partnership rests on Eaglepoint AI’s Aquila data engine.

Haoxi Health, on the other hand, provides the essential commercial bridge. While Eaglepoint supplies the 'brain' of the operation, Haoxi contributes the 'nervous system'—a vast marketing network and established channel resources. This division of labor addresses one of the primary hurdles for AI startups in the healthcare space: user acquisition and commercial conversion. By leveraging Haoxi’s existing reach, the partnership aims to bypass the slow adoption cycles typically associated with new health technologies. The first phase of this rollout is the 'AI Digital Health Manager,' a SaaS system designed to provide immediate value to users through intelligent nutrition tracking and preliminary health assessments. This initial product serves as a data-gathering tool that will likely feed back into the Aquila engine to refine future iterations of the platform.